Mid-states Share Discussion Threads

[baggywrinkle] 20/9/2007 17:48

inov8 was the conference sponsor

[callumross] 20/9/2007 11:29

Exhibiting the new product at a major healthcare conference yesterday


Health Protection 2007
17-19 September, Warwick University
This conference, presented by the Health Protection Agency, is the leading multi-disciplinary health protection conference in Europe, showcasing the latest scientific research and its application to practice.

Attending Health Protection 2007 is a must for health and scientific professionals working across the breadth of health protection wanting to update their knowledge and expertise.

Full details are available on the exhibition website: www.healthprotectionconference.org.uk

Please come and visit the INOV8 Science exhibit on stand 26.

[ronmikeh] 28/8/2007 10:44

Just purchased 10,000 at 32p.Looks like a speculative investment,but likes the story. Id contracts are won in the health service, could take off.

[mbaxter] 16/8/2007 18:35

Snap - same strategy for me. Problem is that I buy 'sound' businesses via spreadbets and use cash for the more risky positions. Happy with the strategy and not looking to change but with the sort of bloodbath we are having now, one needs deep pockets and a cast iron constitution to stomach the volatility. Plenty of constitution here, not too sure about the depth of my pockets after the wild gyrations on some of my stocks! Also, don't feel that we have reached the bottom yet - some good old fashioned panicking to be done by the herd.

[callumross] 16/8/2007 18:16

yes - my patience is not as good as yours - I bought 3 battered down stocks today - all asset or earnings backed for security - I have no idea whether we are at or near the bottom but as long as you have faith in the underlying businesses and management then on a longer term view you should be OK. I only bought 25k MST (at one time I had 150k)

[mbaxter] 16/8/2007 17:45

Callumross - LOL. Nice to be in that position. With bargains galore at the moment, struggling to be patient and keep my hands in my pocket.

[callumross] 16/8/2007 16:26

much to my surprise I found myself taking a tentative position again at the close today!!

[smashingguy] 02/8/2007 21:21

Huge buys at the end of play today. 100ks and 50ks
Something is happening!!

[imprima2] 02/8/2007 11:40

We need a little treat of blue to make this nice

[smashingguy] 02/8/2007 10:03

50k market maker cross, full offer of 37p

[smashingguy] 02/8/2007 07:41

Chart looking like it should be ready to run with Wall Street favourable close

[smashingguy] 01/8/2007 14:08

Hope everyone noticed that today we have a fourth market maker join the party.

[smashingguy] 01/8/2007 13:49

No ells, that is incorrect. The device from Airclear is a simple particulate filter and is not based on natural olefins and ozone to produce hydroxyl radicles.
Mid states technology comes from Porton Down, which is part of the Mod.

Looking very likely this is going to head towards 60p on the next news announcement.

CH

[ellales] 01/8/2007 09:17

1st August 07,

DO YOU ALL KNOW THAT MID STATES IS NOT THE ONLY COMPANY IN THE MANUFACTURE & SUPPLY OF THESE TYPES OF OF UNITS ? NOTE AIRCLEAR (WWW.AIRCLEAR.EU.COM)THIS COMPANY IS ALREADY MARKETING THEIR UNITS TO THE GENERAL PUBLIC. MID STATES DO NOT HAVE SOLE ACCESS TO THE MARKET. !!!!

[imprima2] 31/7/2007 12:30

Good luck son. Im still hoping the US launch will see this double from here. Remember not just MRSA but C Diff, flu, cold, anthrax spores, bird flu....anything viral or bacterial has been destroyed with the device.

In my books this is worth a flyer to see it go towards 100p or 500p, who knows!

dyor, and if you like, fyb

[mjcrockett] 31/7/2007 09:40

I may regret this, but after many years as a MST shareholder I have now sold all of my holdings. In my view, the share price has got ahead of itself. Whilst the MRSA Zapper is very exciting, there are risks and it will, in my view, be some while before it is producing substantial revenues. My other worry is the automotive business. It lost getting on for £1m in the half year to 31/12/06 and the outlook statement was not positive. So with a MCap of nearly £30m there is too much value put on future hopes - IMO.

Good luck

MJ

[stegrego] 30/7/2007 21:58

Imprima2 - if you are wondering why the sudden interest - it was tipped in SCSW at the weekend

[imprima2] 30/7/2007 14:24

was 40p last week, so the recovery is only halfway there.

[imprima2] 30/7/2007 10:45

Good move. newsflow of US launch imminent?

[1ch] 24/7/2007 10:23

Just profit taking, probably right for those who bought some time ago -
but where will it level off - 33p 28p 23p or 18p ?

The question is will MST get those badly needed orders to support the current share price. Shareholders in MST should take a look at the history of EQT.

[samuri19] 23/7/2007 13:36

Some profit taking(PT) going on, expected after the recent rise. Once the PT's have gone we should continue the move north.

[samuri19] 23/7/2007 11:12

Trying to get in cheaper ladz????? LOL.

[1ch] 23/7/2007 10:47

trader_clive - Agree - comparisons with EQT, ULT both dealing with the NHS need to be drawn, along with SEO which had a mega capitalisation and little turnover.

MST in a years time could be worth 5p or 300p depending on positive orders coming in. A lot is currently in the price in anticipation.

[trader_clive] 23/7/2007 08:44

This rating is bit like SEO some time ago, and when they did not get the orders from Asda one can imagine what happened to the share price at 28p then, compared to now. We saw very small turnover then compared to a massive capitalisation, but tremendous potential which did not materialise.

Lets hope MST get those orders they need!

[oiliphant] 21/7/2007 22:25

New Scientist, remember reading this at school

Radical bug zapper

UK hospitals are to start trials of a device that may reduce hospital superbugs to undetectable levels in air and on surfaces. The Air Disinfector discharges highly reactive hydroxyl radicals which rapidly kill microbes, says its maker, Inov8 Science of Buckingham, UK.



`Lifesaver' with roots in germ warfare
Email story
Print
Choose text size
Report typo or correction
Email the author
License this article
Tag and save

'It sounds very simple, but getting it to work is very complex'
David Macdonald Inspired by research in the '60s, a new device could do wonders in the fight against superbugs

Jul 08, 2007 04:30 AM
Bill Taylor
Feature Writer

Remember how your grandma, whatever the weather, insisted upon opening the windows because "fresh air's good for what ails you?"

Turns out she was right. The realization could not only be a lifesaver in hospitals, it could become our best weapon if the much-feared avian-flu pandemic becomes a reality. It could also bring an end to "sick-building syndrome."

It's not practical to keep hospital or office highrise windows open to the elements, especially in the smog-beset GTA. But two British scientists have invented a device that, in a manner as simple and elegant as its name – the Air Disinfector, or AD – emulates the natural cleansing effect of fresh air.

It could, they say, help rid hospitals of the deadly "superbugs" that have defied all efforts to eradicate them and cause needless deaths among patients. A room "flooded ... with more than a million bacteria," can be completely cleansed "down to zero within an hour," says David Macdonald, chief scientific officer of Inov8 Science.

He developed the 47-by-13-centimetre device – about the size of a vase – with Derek Ellwood, at one time a senior microbiologist at the British government's Porton Down chemical and biological warfare labs.

On the phone from England, Macdonald explains how it came about: "Back in the 1960s, Western governments were worried about a biological airborne attack. What had been known for a long time was that during the day, pathogens – bacteria and viruses – only exist in the open air for seconds. What wasn't known was if the same effect happened at night. Porton Down was commissioned to find out, and discovered they were killed even more rapidly at night ... something to do with the ozone in the atmosphere.

"They had no idea at the time what was causing the death of the pathogens. They simply called it the open-air factor, and it was impossible to isolate this in an enclosed space. And bacteria can last for many days in an enclosed room."

The government downgraded the threat of attack and cut the program's funding. Ellwood, one of the key researchers, began working with Macdonald 15 years ago.

Experiments showed that in the open air, a natural reaction between ozone and "terpenes" – scented chemicals from plants and trees – produces "hydroxyl radicals" (basically, a molecule of hydrogen and oxygen) that kill germs almost instantaneously.

"You can see the effect if you look at a pine forest on a very sunny day," Macdonald says. "There's a very faint, blue haze. It's the reaction between the ozone given off in very hot weather and the scent."

The AD reproduces this, he says, by sucking in oxygen, exposing it to electric currents to produce ozone, which reacts with terpenes contained in renewable cartridges. It's not, he says, like hanging a potent air-freshener in your car. "There's a very faint scent of oranges. Almost nothing.

"It sounds very simple, but getting it to work is very complex. I suppose you could call me the engineer who built the thing, someone who's learned a bit about microbiology over the past decade."

The AD is being tested in several British hospitals and office buildings and next year will be tried in 17 U.S. Veterans Administration hospitals, Macdonald says.

The price is being worked out, "but if you could afford a beer a day or a pack of cigarettes, that should cover it. It plugs in, just like a phone charger, sits quietly in a corner, and runs 24-7. Once a month, you replace the cartridge."

The Inov8 team knows the AD works, he says. "What we don't know is if, with different viruses, it's 99 per cent effective, 95 or 90. No less than that. In the case of influenza, including bird flu, we think it's 99 per cent. If you spend all your time in the fresh air, you're very unlikely to pick up influenza. You get these infections inside buildings. We know that sick-building syndrome is caused by organisms that float in the air. People who live, work and drive in an air-conditioned environment are always susceptible. We're not intended as a species to live in closed boxes."

The two worst hospital superbugs, Staphylococcus aureus (more commonly known as MRSA) and Clostridium difficile (C.diff), are resistant to antibiotics and, over the decades, have been become stronger and more virulent. Scientists have known for half a century that they're airborne pathogens. But conventional methods of cleaning and disinfecting were ineffective.

The offender, Macdonald says, is skin. "Each of us is shedding about 60,000 microscopic pieces of skin every minute, and every piece carries a cargo of bacteria. If you shine a really bright light, you'll see specks dancing in the air. They're the larger pieces. Outside, the bacteria are killed right away. Inside, they're not."

According to Clive Beggs, a medical technology professor who is on Inov8's advisory board, in a two-bed hospital room there could be more than 12,000 of these flakes per cubic metre. They spread through the hospital on air currents and settle on everything – beds, tables, floors, door frames. From there, they get onto the hands of patients, nurses and doctors.

"In recent years, there's been more emphasis on cleaning hospitals," Beggs says in an Inov8 news release. "We're washing hands more than ever before, but infections are not coming down. In my opinion, the aerial route is the most significant source of contamination. Patients shed skin into bedclothes. When beds are made or curtains are drawn, clouds of skin flakes go into the air. The airborne link in the chain of infection is the weakest link, and one which gives ... the best opportunity to break the infection chain."